Nao Tuchida

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

R. Mori, Y. Ohashi, K. Nakanishi, 2014, The Lancet.

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

R. Mori, Y. Ohashi, K. Nakanishi, 2014, The Lancet.